DrugPatentWatch Database Preview
Drugs in Development Information for Pracinostat
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Pracinostat?
Pracinostat is an investigational drug.
There have been 10 clinical trials for Pracinostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2017.
The most common disease conditions in clinical trials are Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are MEI Pharma, Inc., Helsinn Healthcare SA, and Medical College of Wisconsin.
There are seven US patents protecting this investigational drug and sixty-five international patents.
Summary for Pracinostat
| US Patents | 7 |
| International Patents | 65 |
| US Patent Applications | 29 |
| WIPO Patent Applications | 21 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-06-01) |
| Vendors | 57 |
Recent Clinical Trials for Pracinostat
| Title | Sponsor | Phase |
|---|---|---|
| Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) | Medical College of Wisconsin | Phase 1 |
| A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body | Quotient Sciences | Phase 1 |
| A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body | Helsinn Healthcare SA | Phase 1 |
Clinical Trial Summary for Pracinostat
Top disease conditions for Pracinostat
Top clinical trial sponsors for Pracinostat
US Patents for Pracinostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pracinostat | Start Trial | Heterocyclic compounds | S*BIO Pte Ltd. (Singapore Science Park II, SG) | Start Trial |
| Pracinostat | Start Trial | Methods and compositions for treatment of autism | The Johns Hopkins University (Baltimore, MD) Kennedy Krieger Institute, Inc. (Baltimore, MD) | Start Trial |
| Pracinostat | Start Trial | RbAp48 transgenic mice for drug discovery in age-related memory decline | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, NY) | Start Trial |
| Pracinostat | Start Trial | System and method of producing volatile organic compounds from fungi | Start Trial | |
| Pracinostat | Start Trial | Method of treating leukemia using pharmaceutical formulation containing thienotriazolodiazepine compounds | Merck Sharp & Dohme Corp. (Rahway, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pracinostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pracinostat | Argentina | 055364 | 2025-09-08 | Start Trial |
| Pracinostat | Argentina | 105930 | 2025-09-08 | Start Trial |
| Pracinostat | Austria | 512953 | 2025-09-08 | Start Trial |
| Pracinostat | Australia | 2006201177 | 2025-09-08 | Start Trial |
| Pracinostat | Brazil | PI0615690 | 2025-09-08 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
